Effective AbobotulinumtoxinA Split Face Dose Response Study for Upper Facial Wrinkles
Status:
Not yet recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
This research is being done to determine if lower doses of botox than what is currently
recommended can give similar results to patients, at lower cost and lower risk to them.
Subjects will receive botox in the same areas of the upper face with standard doses on one
side of the face. On the other side, double the botox concentration will be administered,
free of charge to the participant, in order to see if the difference in concentration creates
a difference in wrinkle reduction and participant satisfaction over time.